Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

Stivarga®

	Next higher product group	regorafenib (BAY 73-4506)
	Status	2012-09-27 registration start
	Organisation	Bayer HealthCare AG
	Group	Bayer (Group)
	Organisation 2	Onyx Pharmaceuticals Inc.
	Group	Amgen (Group)

Record changed: 2023-07-10

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for cancer drug_o

[1] Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt....
[2] Boundless Bio, Inc.. (5/16/23). "Press Release: Boundless Bio Announces $100 Million Oversubscribed Series C Financing Co-led by Leaps by Bayer and RA Capital Management". San Diego, CA....
[3] Leap Therapeutics, Inc.. (1/17/23). "Press Release: Leap Therapeutics Acquires Flame Biosciences". Cambridge, MA....
[4] Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin....
[5] Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin....
[6] Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt....
[7] Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan"....
[8] Debiopharm International SA. (6/12/19). "Press Release: Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for another 15 Years". Lausanne & Paris....
[9] SOM Biotech S.L.. (3/7/19). "Press Release: SOM Biotech Closes a Financing Round of 7m Euros". Barcelona....
[10] Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]